A book offers a detailed introduction to the new area of risk evaluation and mitigation strategies.
R. Gary Hollenbeck
Advertisement
R. Gary Hollenbeck, PhD, is chief scientific officer at UPM Pharmaceuticals, adjunct professor of pharmaceutical sciences at the University of Maryland School of Pharmacy, and a member of Pharmaceutical Technology's editorial advisory Board,.
Articles by R. Gary Hollenbeck
Advertisement
Latest Updated Articles
- Are You Ready for REMS?
Published: October 2nd 2008 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
AI and Accelerated Computing Propel the Biopharma Ecosystem Forward
2
Takeda Talks at CPHI Frankfurt 2025 About Smart Pharma Packaging Impacts
3
Thermo Fisher Launches OpenAI Partnership at CPHI Frankfurt 2025: Part One
4
Sustainability and Stability in Excipients
5
